Cargando…

Acrolein, a New Villain in the Development of Alcoholic Liver Disease

Detalles Bibliográficos
Autor principal:	Seki, Ekihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042884/ https://www.ncbi.nlm.nih.gov/pubmed/28174735 http://dx.doi.org/10.1016/j.jcmgh.2016.06.005

Ejemplares similares

Nuclear Receptors: Opening Up New Avenues of Pediatric Fatty Liver Research
por: Pandyarajan, Vijay, et al.
Publicado: (2018)

Intestinal Lipolysis Mitigates Nonalcoholic Fatty Liver Disease: New Roles for Carboxylesterase 2c in the Intestine
por: Pimienta, Michael, et al.
Publicado: (2019)

FAP: Not Just a Biomarker but Druggable Target in Liver Fibrosis
por: Kim, Jieun, et al.
Publicado: (2023)

Alcoholic liver disease: A current molecular and clinical perspective()
por: Ohashi, Koichiro, et al.
Publicado: (2018)

Is PI3K a Villain in Cystic Fibrosis?
por: Natarajan, Viswanathan
Publicado: (2020)

Tumor Suppressor Down-Regulation Promotes Hepatocyte Proliferation: A New GANKster on the Block
por: Pimienta, Michael, et al.
Publicado: (2018)

Toll-Like Receptor Signaling in Liver Diseases
por: Szabo, Gyongyi, et al.
Publicado: (2010)

Basic and Clinical Advances in Chronic Liver Inflammation
por: Enomoto, Hirayuki, et al.
Publicado: (2016)

Acrolein Is a Pathogenic Mediator of Alcoholic Liver Disease and the Scavenger Hydralazine Is Protective in Mice
por: Chen, Wei-Yang, et al.
Publicado: (2016)

Hyperglycemia in the pediatric intensive care unit: Innocent bystander or villain of the piece?
por: Ranjit, Suchitra
Publicado: (2014)

Heroes and Villains of Finance
por: Baldwin, Adam
Publicado: (2015)

A New Perspective of an Old Villain: Revisiting Biomarkers of Caries Development
por: Freires, Irlan Almeida, et al.
Publicado: (2017)

TAK1-dependent autophagy: A suppressor of fatty liver disease and hepatic oncogenesis
por: Seki, Ekihiro
Publicado: (2014)

Acrolein
por: Gómes, R.
Publicado: (2002)

A new mechanism of action of glucagon‐like peptide‐1 agonist in hepatic steatosis: Promotion of hepatic insulin clearance through induction of carcinoembryonic antigen‐related cell adhesion molecule 1
por: Czech, Torrey Y., et al.
Publicado: (2018)

Crossing the Rubicon: Adipose Tissue Autophagy Breaks Out NAFLD
por: Kim, Jieun, et al.
Publicado: (2021)

Science heroes and villains of 2008
Publicado: (2008)

Kupffer Cell TLR2/3 Signaling: A Pathway for EGCG Amelioration of Ethanol-Induced Hepatic Injury
por: Czech, Torrey Y., et al.
Publicado: (2019)

Thrombotic Thrombocytopenic Purpura After Live Liver Donation: Villain or Scapegoat?
por: Udayasankar, Madhumita, et al.
Publicado: (2021)

CaMKII: The molecular villain that aggravates cardiovascular disease
por: Zhang, Peiying
Publicado: (2017)

The Renin-Angiotensin System in Huntington’s Disease: Villain or Hero?
por: Machado, Thatiane C.G., et al.
Publicado: (2020)

Monocytes and Macrophages in Synovitis: Villains or Victims?
por: Burmester, Gerd R, et al.
Publicado: (2000)

Cancer-associated fibroblasts—heroes or villains?
por: Gieniec, Krystyna A., et al.
Publicado: (2019)

To the Editor—Atropine: Hero or villain in cardioneuroablation?
por: Pachon-M, Jose Carlos, et al.
Publicado: (2022)

Role of Toll-Like Receptors and Their Downstream Molecules in the Development of Nonalcoholic Fatty Liver Disease
por: Miura, Kouichi, et al.
Publicado: (2010)

Enterobacter cloacae: a villain in CaOx stone disease?
por: Yang, Yuanyuan, et al.
Publicado: (2022)

Dietary inorganic nitrate: From villain to hero in metabolic disease?
por: McNally, Ben, et al.
Publicado: (2015)

“Heroes” and “Villains” of World History across Cultures
por: Hanke, Katja, et al.
Publicado: (2015)

Fixed Drug Eruption to Cetirizine: An Unusual Villain
por: Ardeshna, Kenit P., et al.
Publicado: (2018)

Exacerbation of asthma and airway infection: is the virus the villain?()()
por: Costa, Lusmaia D.C., et al.
Publicado: (2014)

Glucose and glycogen in the diabetic kidney: Heroes or villains?
por: Sullivan, Mitchell A., et al.
Publicado: (2019)

Exacerbation of asthma and airway infection: is the virus the villain?()()
por: Costa, Lusmaia D.C., et al.
Publicado: (2014)

Villains or heroes? The raison d'être of viruses
por: Watanabe, Tokiko, et al.
Publicado: (2020)

T-type channels in neuropathic pain - Villain or victim?
por: Weiss, Norbert
Publicado: (2020)

Macrophages in the pancreas: Villains by circumstances, not necessarily by actions
por: Cruz, Andrea F., et al.
Publicado: (2020)

Author’s Reply—Atropine: Hero or villain in cardioneuroablation?
por: Thurber, Clinton J., et al.
Publicado: (2022)

Toll-Like Receptors in Liver Fibrosis: Cellular Crosstalk and Mechanisms
por: Yang, Ling, et al.
Publicado: (2012)

Acrolein scavenger dimercaprol offers neuroprotection in an animal model of Parkinson’s disease: implication of acrolein and TRPA1
por: Shi, Liangqin, et al.
Publicado: (2021)

Hyaluronan in liver fibrosis: basic mechanisms, clinical implications, and therapeutic targets
por: Kim, Jieun, et al.
Publicado: (2023)

199. Infections in VADers: A True Villain of the Force
por: Seidelman, Jessica, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_s71m35q242hfk135t1cf0lhfta